Clinical trial
The Impact of Growth Hormone in Obese Cases With Covid-19
NCT04532554 is registered in ClinicalTrials.gov with ClinAmygate as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Growth Hormone in Obese Cases With Covid-19
- Lead sponsor
- ClinAmygate
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- October 26, 2020
- Completion date
- December 20, 2020
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19